Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Sodium Glucose Cotransporter 2 Inhibitors in the Management of Patients With Aortic Stenosis

NCT06469645 is registered in ClinicalTrials.gov with University of East Anglia as lead sponsor.

NCT NCT06469645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06469645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Sodium Glucose Cotransporter 2 Inhibitors in the Management of Patients With Aortic Stenosis
Lead sponsor
University of East Anglia
Phase
Phase 2/3
Overall status
Completed
Start date
May 30, 2024
Completion date
July 24, 2026
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate aortic valve stenosis